Business and government want your genetic data. They will ensure they get hold of it, one way or another, either in collusion with each other or independently.

The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

I am fascinated to see what certifications support their career endeavor. 90% of the profiles I have come across lately have limited to no education or experience.

The Gambling Capital of the World is an Ideal Setting for Health-Sector Predictions